SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Welcure Drugs & Pharmaceuticals informs about trading window closure

27 Jun 2022 Evaluate
Welcure Drugs & Pharmaceuticals has informed that the Trading Window for dealing in the securities of the Company will be closed for ‘Designated Persons' from Tuesday, June 28, 2022 and the same shall remain closed till 48 hours after announcement of Financial Results for the quarter ended June 30, 2022 to the stock exchanges. Accordingly, the Designated Persons have been intimated not to trade in the securities of the Company during the aforesaid period of closure of Trading Window.

The above information is a part of company’s filings submitted to BSE.

Welcure Drugs&Pharma Share Price

0.31 -0.01 (-3.13%)
23-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Redington 220.70
Adani Enterprises 2300.50
Amrapali Industries 17.45
Rashi Peripheral 475.55
PDS 285.60
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×